Viewing Study NCT05892718


Ignite Creation Date: 2025-12-25 @ 4:35 AM
Ignite Modification Date: 2026-04-23 @ 1:30 PM
Study NCT ID: NCT05892718
Status: RECRUITING
Last Update Posted: 2025-07-01
First Post: 2023-05-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Safety and Efficacy Study of HCB101, Fc-fusion Protein Targeting SIRPα-CD47 Pathway, in Solid or Hematological Tumors
Sponsor: FBD Biologics Limited
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Solid Tumor View
None Refractory Non-Hodgkin Lymphoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Immunotherapy View
None CD47 View
None SIRPα View
None Solid Tumor View
None Lymphoma View